| Authors: |
Scanlan J; Mass Spectrometry & Proteomics Group, Centre for Pharmaceutical Innovation, College of Health, Adelaide University, Adelaide, South Australia, Australia., Mittal P; Mass Spectrometry & Proteomics Group, Centre for Pharmaceutical Innovation, College of Health, Adelaide University, Adelaide, South Australia, Australia., Washington J; Mass Spectrometry & Proteomics Group, Centre for Pharmaceutical Innovation, College of Health, Adelaide University, Adelaide, South Australia, Australia., Young C; Mass Spectrometry & Proteomics Group, Centre for Pharmaceutical Innovation, College of Health, Adelaide University, Adelaide, South Australia, Australia., Antoniou M; Centre for Cancer Biology, An Alliance Between SA Pathology and Adelaide University, Adelaide, South Australia, Australia.; Adelaide Medical School, College of Health, Adelaide University, Adelaide, South Australia, Australia., Kochetkova M; Centre for Cancer Biology, An Alliance Between SA Pathology and Adelaide University, Adelaide, South Australia, Australia., Oehler MK; Robinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.; Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Hoffmann P; Mass Spectrometry & Proteomics Group, Centre for Pharmaceutical Innovation, College of Health, Adelaide University, Adelaide, South Australia, Australia., Klingler-Hoffmann M; Mass Spectrometry & Proteomics Group, Centre for Pharmaceutical Innovation, College of Health, Adelaide University, Adelaide, South Australia, Australia. Manuela.klingler-hoffmann@adelaide.edu.au. |
